Subscalp EEG system feasible for long-term seizure monitoring

A subscalp EEG system proved feasible for long-term seizure monitoring in patients with epilepsy, Healio reports, marking a practical step toward continuous, ambulatory electrophysiology outside the conventional video-EEG monitoring unit.

The finding addresses one of the most persistent bottlenecks in epilepsy care: scalp EEG captures interictal and ictal data well in supervised inpatient settings, but electrodes detach, artifacts accumulate, and adherence collapses once patients go home. For the roughly one-third of patients whose seizures remain unlocalized after routine evaluation — and for candidates being considered for epilepsy surgery or neuromodulation — the gap between short admissions and months of real-world seizure behavior is where clinical decisions stall.

Subscalp EEG occupies a deliberate middle ground between modalities. Electrodes sit under the scalp but outside the skull, so the system avoids the infection profile and operative burden of fully intracranial grids and stereo-EEG electrodes, while recording closer to the generator than surface montages allow. That position is what makes the feasibility result notable for reading-room practice: it suggests a recording route that could run for months, not days, without the gel, wire management, and technician time that make prolonged scalp studies impractical.

What does feasibility mean for the monitoring unit?

The report frames the system as workable for extended seizure monitoring rather than as a diagnostic replacement. In practical terms, that points to three use cases monitoring teams will recognize immediately:

• Surgical candidacy workup, where ictal recordings must accumulate over weeks because seizures are infrequent
• Quantification of electrographic seizure burden in pharmacoresistant patients, including those on investigational or newly adjusted antiseizure medications
• Post-implant surveillance of neuromodulation devices such as responsive neurostimulation, where objective seizure counting still depends heavily on patient diaries known to miss a substantial share of events

Each application hinges on the same property the feasibility finding supports: recording stability over long horizons in patients living normally, not confined to a bed in an epilepsy monitoring unit.

How does it compare with existing options?

Any subscalp system enters a field defined by trade-offs. Scalp video-EEG remains the reference standard for seizure classification and remains noninvasive, cheap, and repeatable — but effectively confined to short inpatient stays. Intracranial EEG offers unmatched signal fidelity and spatial resolution for delineating seizure onset zones, at the cost of a craniotomy or burr-hole procedure, limited implant duration, and complication risk that restricts it to selected surgical candidates. Wearable devices and pulse sensors can count convulsive events over long periods, yet they largely miss nonconvulsive and focal seizures with limited motor signature — precisely the population where electrographic confirmation matters most.

A subscalp platform aims to deliver EEG-grade ictal data on a timescale comparable to wearables. That combination, if subsequent studies validate detection sensitivity and false-alarm rates against expert scalp review, would give epileptologists something the current toolkit lacks: continuous, high-fidelity brain signals from the patient's own environment.

What questions remain open?

A feasibility result is a beginning, not an endorsement for routine deployment. Key uncertainties will shape how quickly monitoring units adopt the approach: agreement between subscalp ictal patterns and conventional scalp or intracranial findings, electrode longevity and revision rates, the logistics of remote data review, and whether payer systems will reimburse prolonged ambulatory EEG the way they reimburse inpatient monitoring. The regulatory pathway also matters — readers should watch for whether the system proceeds under an investigational device framework or pursues clearance for a defined epilepsy-monitoring indication.

For now, the study's contribution is concrete: it demonstrates that subscalp recording hardware can operate as a long-term seizure-monitoring platform in people with epilepsy. Upcoming comparative work quantifying seizure-detection performance against standard scalp EEG will determine whether that platform moves from feasible to foundational in everyday epilepsy practice.